Vowel Space Expansion Sensorimotor Adaptation
Launched by UNIVERSITY OF WISCONSIN, MADISON · Jan 22, 2024
Trial Information
Current as of June 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Vowel Space Expansion Sensorimotor Adaptation," aims to learn how our brains control and process speech, especially how we notice and correct our own speech mistakes. Researchers hope to understand how people learn to produce new speech sounds. The study will involve 117 healthy adults who speak English and have normal hearing and speech abilities. Participants should not have any history of stroke or neurological disorders.
If you join this study, you can expect to be involved for a short time, ranging from just one day to up to four weeks, depending on the part of the research you're participating in. To be eligible, you should be between the ages of 65 and 74 years, and you must be able to understand and communicate in English. The study is currently recruiting participants, so if you or someone you know fits these criteria, it could be a great opportunity to contribute to important research in understanding speech.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English-speaking adults
- • normal hearing and speech
- • no history of stroke or neurological conditions
- Exclusion Criteria:
- • Native language other than English
- • Any neurological disorders other than the disorder of interest
- • Any history of hearing disorders
- • Uncorrected vision problems that prevent participants from seeing visually-presented stimuli
- • Significant cognitive impairments that prevent participants from carrying out the task or from giving informed consent
- • Vulnerable populations (minors and prisoners)
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Carrie Niziolek, PhD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported